Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06428006

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis (CALM)

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms and Fatigue in Individuals With Multiple Sclerosis

Sponsor: University of Kansas Medical Center

Conditions Insomnia Multiple Sclerosis

Interventions Cognitive behavioral therapy for insomnia Sleep and lifestyle education

Updated 2 times since 2024 Last updated: Jul 16, 2025 Started: Jul 30, 2024 Primary completion: May 31, 2027 Completion: May 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06428006, this PHASE2 trial focuses on Insomnia and Multiple Sclerosis and remains actively recruiting participants. Sponsored by University of Kansas Medical Center, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE2

First recorded

Jul 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Kansas Medical Center

Data source: University of Kansas Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States